Abstract:The ever-growing biopharmaceutical industry relies on the production of recombinant therapeutic proteins in Chinese hamster ovary (CHO) cells. The traditional timelines of CHO cell line development can be significantly shortened by the use of targeted gene integration (TI). However, broad use of TI has been limited due to the low specific productivity (qP) of TI-generated clones. Here, we show a 10-fold increase in the qP of therapeutic glycoproteins in CHO cells through the development and optimization of a multicopy TI method. We used a recombinase-mediated cassette exchange (RMCE) platform to investigate the effect of gene copy number, 5′ and 3′ gene regulatory elements, and landing pad features on qP. We evaluated the limitations of multicopy expression from a single genomic site as well as multiple genomic sites and found that a transcriptional bottleneck can appear with an increase in gene dosage. We created a dual-RMCE system for simultaneous multicopy TI in two genomic sites and generated isogenic high-producing clones with qP of 12–14 pg/cell/day and product titer close to 1 g/L in fed-batch. Our study provides an extensive characterization of the multicopy TI method and elucidates the relationship between gene copy number and protein expression in mammalian cells. Moreover, it demonstrates that TI-generated CHO cells are capable of producing therapeutic proteins at levels that can support their industrial manufacture.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssynbio.0c00322?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssynbio.0c00322</a>.Verification of D1–D3 cell pools and R1–R6 clones; multicopy plasmid verification (EPO4, EPO6); verification of EPO1–EPO6 and ETN1–ETN4 clones; verification of MP3 and LC1 master cell lines and clones AD1_EPO1(R1), MP3_EPO1 and LC1_EPO1; verification of dual-RMCE BP5 master cell line and NP clones; verification of dual-RMCE EPO clones; verification of dual-RMCE ETN clones; analysis of ETN protein quality by N-glycan analysis and Western blot; fed-batch cultivation of two EPO2_EPO2 clones; RMCE integration efficiency for cell designs EPO1–EPO6 and ETN1-ETN6; RMCE integration efficiency for dual-RMCE EPO and ETN clones; plasmids used and created in this study; list of extended USER linkers with restriction sites; primers used for verification of targeted integration; TaqMan assays; supporting sequence data (<a class="ext-link" href="/doi/suppl/10.1021/acssynbio.0c00322/suppl_file/sb0c00322_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A high‐fidelity, dual site‐specific integration system in CHO cells by a Bxb1 recombinase

Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system

A system for site-specific integration of transgenes in mammalian cells

Enhancing Homologous Recombination Efficiency in Pichia Pastoris for Multiplex Genome Integration Using Short Homology Arms.

Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange.

Construction and application of a multifunctional CHO cell platform utilizing Cre/ lox and Dre/ rox site-specific recombination systems

Enhancing stability of recombinant CHO cells by CRISPR/Cas9-mediated site-specific integration into regions with distinct histone modifications

Hybrid cell line development system utilizing site-specific integration and methotrexate-mediated gene amplification in Chinese hamster ovary cells

Multicopy Targeted Integration for Accelerated Development of High-Producing Chinese Hamster Ovary Cells

Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway

Construction of a CHO cell line with site-specific integration to stably express exogenous proteins using the CRISPR–Cas9 technique

Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35

High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors

Increased stable integration efficiency in CHO cells through enhanced nuclear localization of Bxb1 serine integrase

High-fidelity large-diversity monoclonal mammalian cell libraries by cell cycle arrested recombinase-mediated cassette exchange

Homologous Recombination-Independent Large Gene Cassette Knock-in in CHO Cells Using TALEN and MMEJ-Directed Donor Plasmids

Efficient site-specific integration in CHO-K1 cells using CRISPR/Cas9-modified donors

Site-Specific Integration by Circular Donor Improves CRISPR/Cas9-Mediated Homologous Recombination in Human Cell Lines

CRISPR-Cas9 Mediated Stable Expression of Exogenous Proteins in the CHO Cell Line through Site-Specific Integration

A doubly auxotrophic CHO‐K1 cell line for the production of recombinant monoclonal antibodies

Recombinase‐mediated Method for Multi‐scale Genomic Rearrangements